Standard Biotools (LAB) Price to Book (2011 - 2026)

Standard Biotools (LAB) has reported Price to Book for 16 consecutive years, with 0.6 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book fell 44.81% year-over-year to 0.6 in Q2 2026; TTM through Jun 2026 was 0.6, a 44.81% decrease from a year earlier, with the FY2025 full-year figure at 1.17, down 16.77% from the prior year.
• Price to Book was 0.6 for Q2 2026 at Standard Biotools, down from 0.64 in the prior quarter.
• Over five years, Price to Book peaked at 12.53 in Q1 2022 and troughed at 3.36 in Q2 2022.
• A 5-year average of 0.66 and a median of 0.77 in 2026 frame the typical range for Price to Book.
• The widest YoY moves for Price to Book: up 354.74% in 2022, down 178.38% in 2022.
• Over 5 years, Price to Book stood at 1.14 in 2022, then declined by 4.92% to 1.2 in 2023, then soared by 216.94% to 1.4 in 2024, then retreated by 16.77% to 1.17 in 2025, then plunged by 48.91% to 0.6 in 2026.
• The last three Price to Book figures came in at 0.6 (Q2 2026), 0.64 (Q1 2026), and 1.17 (Q4 2025), per Business Quant data.